leonurine has been researched along with angiotensin ii in 5 studies
| Studies (leonurine) | Trials (leonurine) | Recent Studies (post-2010) (leonurine) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
|---|---|---|---|---|---|
| 130 | 1 | 110 | 38,152 | 1,089 | 7,413 |
| Protein | Taxonomy | leonurine (IC50) | angiotensin ii (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, HY; Gong, QH; Huang, GY; Liu, XH; Pan, LL; Wu, D; Xiong, QH; Zhu, YZ | 1 |
| Li, D; Li, G; Lv, D; Ouyang, J; Peng, L; Shang, F; Wang, R; Yan, J; Yang, J | 1 |
| Ding, XL; Qian, HB; Xue, DJ; Yang, FM; Yuan, QQ; Zhu, YZ | 1 |
| Dai, C; Huang, W; Li, W; Li, X; Liang, G; Luo, W; Shen, S; Wu, G | 1 |
| Ouyang, J; Pi, D; Wang, R; Xi, T; Yang, J | 1 |
5 other study(ies) available for leonurine and angiotensin ii
| Article | Year |
|---|---|
Leonurine (SCM-198) attenuates myocardial fibrotic response via inhibition of NADPH oxidase 4.
Topics: Angiotensin II; Animals; Cells, Cultured; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Fibrosis; Gallic Acid; Leonurus; Male; Matrix Metalloproteinase 2; Myocardial Infarction; Myocardium; NADPH Oxidase 4; NADPH Oxidases; NF-kappa B; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction | 2013 |
Leonurine Attenuates Myocardial Fibrosis Through Upregulation of miR-29a-3p in Mice Post-myocardial Infarction.
Topics: Angiotensin II; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen; Disease Models, Animal; Fibroblasts; Fibrosis; Gallic Acid; Male; Mice, Inbred C57BL; MicroRNAs; Myocardial Infarction; Myocardium; Transforming Growth Factor beta; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling | 2021 |
[Effect and mechanism of leonurine on pressure overload-induced cardiac hypertrophy in rats].
Topics: Angiotensin II; Animals; Cardiomegaly; Gallic Acid; Hypertrophy, Left Ventricular; Myocardium; Rats | 2022 |
Leonurine attenuates angiotensin II-induced cardiac injury and dysfunction via inhibiting MAPK and NF-κB pathway.
Topics: Angiotensin II; Animals; Fibrosis; Heart Failure; Mice; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; NF-kappa B; Rats | 2023 |
The p53/miR-29a-3p axis mediates the antifibrotic effect of leonurine on angiotensin II-stimulated rat cardiac fibroblasts.
Topics: Angiotensin II; Animals; Collagen Type I; Fibroblasts; Fibrosis; MicroRNAs; Rats; Tumor Suppressor Protein p53 | 2023 |